» Articles » PMID: 20036013

Retinopathy in Persons Without Diabetes: the Handan Eye Study

Overview
Journal Ophthalmology
Publisher Elsevier
Specialty Ophthalmology
Date 2009 Dec 29
PMID 20036013
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To describe the prevalence and associations of retinopathy in a population-based nondiabetic sample of rural Chinese.

Design: Population-based cross-sectional study.

Participants: We included 6830 Han Chinese aged > or =30 years from 13 villages of Yongnian County, Handan City, Hebei Province, China.

Methods: All participants underwent a standardized interview and extensive examinations including retinal photography, measurement of blood pressure (BP) and fasting plasma glucose (FPG). Diabetes mellitus was defined as either FPG > or = 7.0 mmol/l, use of diabetic medication or a physician diagnosis of diabetes. Photographic grading of retinopathy followed the modified Early Treatment Diabetic Retinopathy Study classification system. Logistic regression models were used to assess associations of retinopathy.

Main Outcome Measures: Any retinopathy.

Results: The prevalence of retinopathy among participants without diabetes was 13.6% (95% confidence interval [CI], 12.6-14.6%). The age and gender standardized prevalence of retinopathy in the Chinese adult population (aged 30+ years) without diabetes was estimated to be 12.1% (95% CI 11.1-12.9%). Independent risk factors associated with retinopathy were age (odds ratio [OR], 1.02 ; 95% CI 1.01-1.03 per year increase), male gender (male vs. female, OR 1.27; 95% CI 1.08-1.49), higher FPG (OR 1.30; 95% CI 1.11-1.53 per mmol/l increase), higher systolic BP (OR 1.15; 95% CI 1.05-1.27 per 10 mmHg increase) and higher diastolic BP (OR 1.16; 95% CI 1.09-1.22 per 10 mmHg increase).

Conclusions: Retinopathy was common among rural Chinese adults without diabetes. Its association with FPG and BP suggests that early microvascular damage is occurring at "high normal" levels of blood glucose and BP.

Citing Articles

Determination of osteopontin in monitoring retinal damage in metabolic syndrome.

DAmico R, Siracusa R, Cordaro M, Fusco R, Interdonato L, Franco G Int J Exp Pathol. 2024; 105(6):206-218.

PMID: 39397270 PMC: 11576325. DOI: 10.1111/iep.12518.


The Eye as the Window to the Heart: Optical Coherence Tomography Angiography Biomarkers as Indicators of Cardiovascular Disease.

Kellner R, Harris A, Ciulla L, Guidoboni G, Verticchio Vercellin A, Oddone F J Clin Med. 2024; 13(3).

PMID: 38337522 PMC: 10856197. DOI: 10.3390/jcm13030829.


Prevalence of and risk factors for diabetic retinopathy in residents with different types of abnormal glucose metabolism with or without hypertension: A suburban community-based cross-sectional study.

Ma Y, Wang H, Jiang J, Han C, Lu C, Zeng S Front Endocrinol (Lausanne). 2022; 13:966619.

PMID: 36004355 PMC: 9393865. DOI: 10.3389/fendo.2022.966619.


The Association Between Diabetic Retinopathy and the Prevalence of Age-Related Macular Degeneration-The Kailuan Eye Study.

Yongpeng Z, Yaxing W, Jinqiong Z, Qian W, Yanni Y, Xuan Y Front Public Health. 2022; 10:922289.

PMID: 35923972 PMC: 9339787. DOI: 10.3389/fpubh.2022.922289.


Hypertensive eye disease.

Cheung C, Biousse V, Keane P, Schiffrin E, Wong T Nat Rev Dis Primers. 2022; 8(1):14.

PMID: 35273180 DOI: 10.1038/s41572-022-00342-0.